Predictors of Duration and Demand of Oxygen Therapy in Hospitalized RT-PCR Positive COVID-19 Patients
Demand of Oxygen Therapy in Hospitalized RT-PCR Positive COVID-19 Patients
Keywords:Oxygen therapy, duration and demand, hospitalized COVID -19 patients.
Background: Among many unexplored and challenging areas of COVID-19, pathophysiology of hypoxia and its management requires special attention for the physicians. The current study aimed to find the predictors of duration and demand of oxygen therapy in RT-PCR positive, hospitalized, COVID-19 patients.
Methods: It was a prospective, multicentered, observational study conducted at Chattagram International Medical College (Isolation Ward, CIMC), Chattogram Medical College (COVID Red Zone) and Parkview Hospital Limited (COVID-19 Ward) from January to June 2021 on hospitalised, RT-PCR positive cases of COVID-19 patients of 18 yrs or above who required supplemental oxygen therapy and gave informed consent to be included in the study. All the participants underwent chest HRCT on initial presentation.
Results: In this study, 85 consecutive patients of confirmed COVID-19 were recruited under the study. Patients required oxygen for a median duration of 6 days and median value of the maximum oxygen requirement was 7 L/min with a range between 1-100 l/min. In patients with no co-morbidity, one co-morbidity and more than one comorbidity, the median duration of oxygen therapy were 4.5 (3.0-7.8) hours and 7.0 (5.0-14.3) hours respectively. Multiple regression was run to predict maximum oxygen duration and maximum oxygen required for the patients from gender, age, smoking pattern, number of comorbidity and HRCT score; only total number of comorbidity and HRCT severity score added statistically significantly to the prediction, p < 0.05.
Conclusion: The results of the study might be helpful in triage of COVID-19 patients, planning as well as clinical decision making.
Bangladesh Medical Res Counc Bull 2023; 49(1): 75-80
How to Cite
Copyright (c) 2023 Mehrunnissa Khanom, Rabiul Alam Md Erfan Uddin, Aniruddha Ghose, A S M Zahed, Mohammad Kamrul Islam, Razaul Karim, A T M Rezaul Karim, Shamim Ara, Rizwan Ahmad, Md Akhtarul Islam Chowdhury, Md Amir Hossain
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms.
Authors retain copyright and grant the journal right of first publication.
Articles in the Bangladesh Medical Research Council Bulletin are licensed under a Creative Commons Attribution 4.0 International License (CC-BY) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).